+

WO2000030695A1 - Mucosal epithelial cell sheet and method for producing the same - Google Patents

Mucosal epithelial cell sheet and method for producing the same Download PDF

Info

Publication number
WO2000030695A1
WO2000030695A1 PCT/JP1999/006517 JP9906517W WO0030695A1 WO 2000030695 A1 WO2000030695 A1 WO 2000030695A1 JP 9906517 W JP9906517 W JP 9906517W WO 0030695 A1 WO0030695 A1 WO 0030695A1
Authority
WO
WIPO (PCT)
Prior art keywords
mucosal epithelial
cells
oral
epithelial cells
cell sheet
Prior art date
Application number
PCT/JP1999/006517
Other languages
French (fr)
Japanese (ja)
Inventor
Minoru Ueda
Original Assignee
Japan Tissue Engineering Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tissue Engineering Co., Ltd. filed Critical Japan Tissue Engineering Co., Ltd.
Priority to AU11860/00A priority Critical patent/AU1186000A/en
Publication of WO2000030695A1 publication Critical patent/WO2000030695A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A61L27/3891Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813Epithelial cells, e.g. keratinocytes, urothelial cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0632Cells of the oral mucosa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Definitions

  • the present invention relates to a mucosal epithelial cell sheet and a method for producing the same, and more particularly to a mucosal epithelial cell sheet formed by forming a plurality of layers of mucosal epithelial cells and a method for producing the same.
  • Living cells and tissues may be transplanted or introduced into living organisms, including humans.
  • tissue may be implanted as a wound dressing.
  • tissue may be implanted as a wound dressing.
  • the part where the tissue of the living body has been partially removed by surgery or accident is replaced with another tissue (graft) to supplement the removed part or improve the appearance.
  • graft tissue
  • Various implants have been used for such purposes.
  • a multi-layered sheet of epidermal cells has the advantage that it can be prepared from its own epidermal cells. There is no rejection reaction in the epidermal cell sheet thus produced, and therefore, the epidermal cell sheet is highly evaluated as a useful explant for burns and the like.
  • epithelial cells isolated from oral mucosal cells have a shorter metabolic cycle than epidermal cells because keratinocytes of the skin, that is, epidermal cells are also unseparated cells. It also has the advantage that it can be maintained for a long period of time without squaring. From these properties, oral mucosal cells are considered to be more useful as tissue for transplantation than epidermal keratinocytes.
  • the mucosal epithelial cell sheet of the present invention is constituted by forming a plurality of layers of the inner lining mucosal epithelial cells that adhere to the teeth continuously to the oral mucosal epithelial cells and form a part of the gingival sulcus. It is characterized in that it is a treated mucosal epithelial cell sheet.
  • the above-mentioned mucosal epithelial cell sheet of the present invention is characterized in that the oral mucosal epithelial cell is derived from one that has adhered to a tooth during tooth extraction and has been separated from gingiva.
  • the method for producing a mucosal epithelial cell sheet of the present invention is characterized in that the oral mucosal epithelial cells forming a part of the gingival sulcus, which adhere to the teeth continuously with the oral mucosal epithelial cells, form a plurality of layers.
  • the method is characterized by a method for producing a mucosal epithelial cell sheet.
  • the method for producing a mucosal epithelial cell sheet is characterized in that the oral rim mucosal epithelial cells are separated from the gingiva while being attached to the teeth during tooth extraction.
  • the method for preparing a mucosal epithelial cell sheet comprises dividing the supporting cells by irradiation with a drug or radiation before co-culturing the supporting cells and the oral mucosal epithelial cells. It is characterized in that it includes the loss of performance.
  • FIG. 1 is a sectional view of a tooth and a gingiva.
  • FIG. 2 is a partially enlarged view of FIG. 1 showing the position of the oral mucosal epithelial cell layer.
  • FIG. 3 is a graph showing the ability of oral mucosal epithelial cells to form a knee.
  • FIG. 4 is a graph showing the growth curve of the oral mucosal epithelial cells.
  • FIG. 5 is a graph showing the growth of oral mucosal epithelial cells.
  • FIG. 6A is a graph showing the antigenicity of oral mucosal epithelial cells
  • FIG. 6B is a graph showing the antigenicity of oral rim mucosal epithelial cells.
  • Fig. 7A is an electron micrograph of a mucosal epithelial cell sheet composed of oral mucosal epithelial cells
  • Fig. 7B is an electron micrograph of a cell sheet composed of oral mucosal epithelial cells
  • Fig. 7C 1 is an electron micrograph of a cell sheet composed of epidermal cells.
  • FIG. 8 is a graph showing the engraftment rate of the mucosal epithelial cell sheet formed from the oral mucosal epithelial cells.
  • the mucosal epithelial cell sheet of the present invention is composed of a plurality of layers of oral mucosal epithelial cells.
  • Oral mucosal epithelial cells are a type of oral mucosal epithelial cells. As shown in FIGS. 1 and 2, the oral mucosal epithelial cells constitute an inner epithelial cell layer 14 which is a part of the gingiva 12 supporting the lower end of the tooth 10. In addition, the oral mucosal epithelial cells adhere to the surface of the enamel layer 16 of the tooth 10 and form a gingival sulcus 18 generally called a periodontal pocket. In the present specification, the oral rim mucosal epithelial cells mean, for convenience, a cell group specified at an anatomical position in a living body.
  • the lining epithelial cell layer 14 is continuous with the oral mucosal cell layer 20, and within the gingiva 12, there is a connective tissue portion 22. It is located.
  • the oral mucosal cell layer 20 is composed of oral mucosal epithelial cells different from the oral mucosal epithelial cells.
  • the oral mucosal epithelial cells have different properties from the oral mucosal epithelial cells arranged on the outer side surface of the gingiva 12 and other parts of the oral cavity.
  • plaque tends to accumulate in the gingival sulcus 18 and bacteria easily proliferate, so the oral lining mucosal epithelial cells in the lining epithelial cell layer 14 are always at risk of bacterial infection .
  • the oral mucosal epithelial cells are specialized to cope with such an environment, unlike similar mucosal epithelial cells.
  • the lining epithelial cells of the oral cavity had much higher dividing ability than the oral mucosal epithelial cells of other sites. This seems to be against bacterial infection and damage. It was also found that the antigenicity was lower than that of oral mucosal epithelial cells at other sites. That is, oral mucosal epithelial cells have the advantage that rejection is less likely to occur than oral mucosal epithelial cells.
  • the mucosal epithelial cell sheet of the present invention has the above-mentioned characteristics of the oral marginal mucosal epithelial cell sheet as it is, and has higher division ability and lower antigenicity than the conventional oral mucosal epithelial cell sheet. In addition, it can be prepared in a short period of time and achieve long-term engraftment.
  • the inner epithelial cell layer 14 composed of the oral inner marginal epithelial cells is continuous with the oral mucosal cell layer 20 of the gingiva 12 as shown in FIG.
  • the inner mucosal epithelial cells are attached to the enamel layer 16 of the tooth 10 on the side of the tooth 10, and the inner mucosal epithelial cells are converted to the oral mucosal cells at the upper end of the gingival sulcus 18. It can be easily isolated by separating it from the layer 20 and detaching it from the enamel layer 16.
  • the method of separating the oral mucosal epithelial cells from the oral mucosal cell layer 20 can be performed by ordinary excision, etc., but the degree of adhesion to the enamel layer 16 depends on the degree of adhesion to the oral mucosal cell layer 20 and connective tissue. Since it is stronger than continuity, it can be separated from the oral mucosal cell layer 20 and the connective tissue part 22 while being attached to the enamel layer 16 when the tooth 10 is extracted. Therefore, it can be easily collected from the extracted tooth 10.
  • the collected inner lining mucosal epithelial cells contain, for example, connective tissue ⁇ debris.
  • the enzyme can be removed using a suitable enzyme such as dispase, trypsin, or nylon mesh.
  • the mucosal epithelial cell sheet of the present invention has properties of oral mucosal epithelial cells, and also retains the structural characteristics of oral mucosal epithelial cells. For example, it is known that oral mucosal epithelial cells have a wider cell gap than oral mucosal epithelial cells at other sites. For this reason, the mucosal epithelial cell sheet of the present invention can be easily specified based on the enlarged cell gap.
  • the form other than these features is the same as other mucosal cell sheets, and can be transplanted to a site where the mucosal cell sheet can be transplanted without a sense of incongruity.
  • the mucosal epithelial cell sheet of the present invention is produced by co-culture with a supporting cell.
  • Supporting cells include, for example, fibroblasts, for example, mouse NIH 3T3 cells, 3T3J2, and Swiss 3T3.From the viewpoint of the thickness and growth rate of the formed mucosal epithelial cell sheet, 3 T3J2 cells are preferred.
  • the supporting cells are preferably subjected to a treatment for eliminating the proliferation ability so as not to interfere with the growth of the oral mucosal epithelial cells.
  • the disappearance of the proliferation ability can be performed by a method well known in the art, for example, treatment with mitomycin C or irradiation.
  • culture is performed using a normal cell culture vessel such as a plastic dish.
  • Propagation of the oral mucosal epithelial cells is performed in the presence of supporting cells. Since the supporting cells such as 3 ⁇ 3 form layers before the oral mucosal epithelial cells, the oral mucosal epithelial cells grow on the supporting cells even if they are seeded simultaneously with the oral mucosal epithelial cells. Therefore, the oral mucosal epithelial cells may be seeded simultaneously with the supporting cells as long as the supporting cells are present at the time of proliferation, or may be seeded thereon after the supporting cells form a layer.
  • Oral rim mucosal epithelial cells can be seeded at a cell density of 1 ⁇ 10 4 cells / cm 2 or higher, while supporting cells are 1 ⁇ 10 cells / cm 2 to l ⁇ 10 3 cells / cm 2 It can be sowed with two or more. If the number of supporting cells is smaller than this, it is not preferable because it cannot sufficiently serve as a supporting cell. In addition, the supporting cells are used to support the growth of the oral mucosal epithelial epithelial cells. This is not preferred because it hinders the growth of the oral mucosal epithelial cells. If the number of oral mucosal epithelial cells is less than this range, it will not be possible to efficiently proliferate, which is not preferable.
  • a growth medium is used for growing oral mucosal epithelial cells on supporting cells.
  • the growth medium used for this purpose can be selected from various media known in the art. By culturing in a growth medium, oral lining mucosal epithelial cells readily form multiple layers. On the other hand, the supporting cells die only by supporting the growth of the mucosal epithelial cells, and are no longer present when the mucosal epithelial cells form multiple layers.
  • EFM epithelial sheet forming medium
  • Transferrin 5 zg / ml, 2 xlO— 9 M triiodothyronine, 1 xl (T 9 M cholera toxin, 0.4 ⁇ g / ml Hyde mouth cortisone, 10 OU / ml penicillin, 0.1 zg / ml It is supplemented with kanamycin, 0.25 / g / ml amphotericin B and 1 Ong / ml human recombinant epidermal growth factor (EGF).
  • EGF epidermal growth factor
  • the multilayered oral mucosal epithelial cells are separated from the culture vessel while maintaining the layer structure. This separation can be performed by methods known in the art, and can be easily performed, for example, by using a suitable enzyme such as dispase to inhibit the adhesion of the basal layer.
  • the obtained mucosal epithelial cell sheet is transplanted into a living body by a method known in the art. Since the mucosal epithelial cell sheet of the present invention is composed of a plurality of layers of oral mucosal epithelial cells, it can be transplanted as it is to a transplant site. Further, the mucosal epithelial cell sheet of the present invention is suitable for transplantation in a humid environment such as the oral cavity and under the skin, but can also be transplanted on the epidermis in contact with the outside world. Transplantation can be performed by directly applying a known method adapted to the oral mucosal epithelial cell sheet.
  • oral mucosal epithelial cells constituting the oral mucosal epithelial cell sheet include: Gene transfer can be performed in the same manner as in the case of the mucosal cells.
  • Gene transfer can be easily performed by introducing a gene to be transferred (target gene) by a conventional method. Since oral mucosal epithelial cells are more undifferentiated than mature cells such as epidermal cells, genes can be introduced more easily than mature cells.
  • Genes of interest include factors useful for increasing graft engraftment efficiency, such as antibiotics and antimicrobial peptides (such as dufensin) to prevent bacterial infection during graft engraftment, Includes factors that promote graft survival, such as platelet growth factor (PDGF), fibroblast growth factor (FGF), and hepatocyte growth factor (HFG). These genes are known in the literature and can be easily obtained from public institutions and the like.
  • PDGF platelet growth factor
  • FGF fibroblast growth factor
  • HFG hepatocyte growth factor
  • a gene for gene therapy can be a target gene.
  • Target genes that can be targeted for such gene therapy include congenital and acquired deficiency factors, such as blood coagulation factors, insulin, various growth factors, tumor suppressor genes, and tumor antigen genes. These genes are easily available as described above.
  • Oral rim mucosal epithelial cells were recovered from the tooth after the tooth extraction process with the consent of a patient who came to the hospital for the purpose of wisdom tooth extraction.
  • the oral mucosal epithelial layer was torn off at the upper end of the gingiva during tooth extraction, and thus was separated from the oral mucosal epithelial cells at other sites.
  • the tooth extraction was performed as aseptically as possible, and the oral mucosal epithelial layer adhering to the extracted tooth was carefully separated from the tooth enamel cement transition.
  • the oral mucosal epithelial layer was washed with a phosphate buffer containing 100 OU / ml penicillin (Sigma, St. Louis, Mo.), lmg / ml kanamycin and 2.
  • amphotericin B (Gibco, Gland Island, NY).
  • PBS PBS
  • the cells were immersed at 4 ° C and then treated with 0.25% trypsin (Gibco, Gland Isl and NY) for 30 minutes at room temperature to separate the cells.
  • Enzyme activity was stopped by washing with DMEM containing 10% fetal calf serum (FBS) (Hyclone, UT). Thereafter, the mixture was stirred in DMEM containing 10% FBS for 30 minutes, and then the debris was filtered with a 50 ⁇ m nylon gauze to isolate the oral mucosal epithelial cells.
  • FBS fetal calf serum
  • oral mucosal epithelial cells In order to confirm the proliferation activity of the oral mucosal epithelial cells, the above-mentioned oral mucosal epithelial cells (hereinafter referred to as inner epithelial cells) and the mucosal epithelial cells at other parts of the oral cavity (hereinafter referred to as oral epithelial cells) ) And the ability to form colonies with epidermal cells and the growth rate were measured.
  • Oral epithelial cells were isolated from the human alveolar gingival mucosa in the oral cavity. Epidermal cells were also isolated from human abdominal skin.
  • the colony forming ability was determined by a known method. Briefly, it is as follows. Into a 25 cm 2 T-type flask (Nunc), inoculate 1 ⁇ 10 3 limbal epithelial cells, oral epithelial cells and epidermal cells, and after 5 days of culture, use methylene blue (SIGMA). Stained. The number of colonies was determined by visual inspection of the stained ones. The results are shown in Figure 3.
  • MTT 3- (4,5-dimethylthiozol-2-yl) -2,5-diphenyltetrazoliumbutamate) (manufactured by SIGMA). Is the way. MTT is a yellowish compound that is degraded by the active mitochondria of living cells to produce a dark blue formazan compound. For this reason, only living cells were stained with this dye, and the relative cell amount was simply measured. The results are shown in FIGS. 4 and 5, respectively.
  • the colony forming ability indicates the growth potential of the cell. As shown in FIG. 3, the colony forming ability of the limbal epithelial cells was about twice that of the epidermal cells, and was significantly higher than that of the oral epithelial cells. In addition, it was shown that the proliferation rate of inner epithelial cells was faster than that of epidermal cells and oral epithelial cells (see FIGS. 4 and 5).
  • lining epithelial cells have the characteristic of having a high proliferative capacity, and are a distinctly different cell group from oral epithelial cells, and can form sheets more rapidly when forming cell sheets. That is, it is suggested that the sheet forming ability is high.
  • Antigenicity was determined by assay of the expression of IA and Thy-1 antigens on both limbal and oral epithelial cells. Atsey's method is as follows.
  • Anti-IA d antibody (Ce clarlane) was applied to the isolated BALB / c mouse cells, and anti-IA k antibody (Becton Dickins on) was applied to C 3 H / Hen mouse cells. After incubation at 4 ° C for 60 minutes, rabbit complement was added, followed by incubation at 37 ° C for 60 minutes.
  • the cells are collected, and FITC-conjugated anti-MHC class II antibody (Becton Dickinson) is added at a concentration of 1/300, and the mixture is incubated at 4 ° C for 45 minutes. After that, the cells were observed with a fluorescence microscope. Next, the numbers of IA antigen-positive cells and Thy-1 antigen-positive cells (dendritic cells) were measured using flow cytometry. Figure 6 shows the results.
  • the expression of Thy-1 antigen and IA antigen in the limbal epithelial cells both decreased with the lapse of the culture period.
  • This IAfc3 ⁇ 4 is considered to be expressed on immunocompetent cells, Langerhans cells, in limbal epithelial cells.
  • the expression of both cell antigens ⁇ 3 ⁇ 4 and Thy-1 ⁇ ⁇ declined with time, suggesting that the immune response became weaker with the passage of the culture period.
  • Thy-1 antigen expression in oral epithelial cells was different from IA antigen expression, and was shown not to decrease even after the culture period. For this reason, oral epithelial cells did not show a decrease in the amount of cellular antigens compared to inner epithelial cells, and after the culture period This suggests that the immune response is not reduced as much as in the limbal epithelial cells.
  • limbal epithelial cells are a group of cells different from oral epithelial cells due to their low aggressiveness and can form cell sheets that are unlikely to undergo rejection even when transplanted. .
  • 3 ⁇ 3-J2 cells as feeder cells were treated with 4 g / ml mitomycin C (Kyowa Ugly, Tokyo) in serum-free DMEM. After 2 hours, PBS (-) was rinsed several times to remove mitomycin C, after trypsinization, so that it can be seeded at a density of 1 X 10 4 cells / cm 2, to prepare a cell suspension.
  • the formed mucosal epithelial cell sheet is composed of oral and inner lining mucosal epithelial cells.
  • the epithelial cell sheet is detached from the dish with dispase (400 PU / ml). Washed twice with PBS.
  • the mucosal epithelial cell sheet of limbal epithelial cells formed as described above was able to be used as a graft after culturing for about 10 days.
  • the oral epithelial cell sheet requires about 2 weeks of culture time. Therefore, the lining epithelial cell sheet is a graft that can be used earlier than the oral epithelial cell sheet. Rukoto has been shown.
  • the mucosal epithelial cell sheet composed of the limbal epithelial cells has a clearly different morphology from the epidermal cell sheet (FIG. 7C).
  • the mucosal epithelial cell sheet composed of oral epidermal cells FIG. 7B
  • the mucosal epithelial cell sheet composed of the inner peripheral epithelial cells had a wider cell gap.
  • Such a wide intercellular space was a characteristic property of the limbal epithelial cells, and was shown to be retained in the mucosal epithelial cell sheet composed of the limbal epithelial cells. It was also confirmed that a mucosal epithelial cell sheet composed of limbal epithelial cells could be identified based on such morphological characteristics.
  • engraftment was performed using mouse cells.
  • lining epithelial cells, oral epithelial cells, and epidermal cells were collected and layered by culturing for a predetermined period. Once the cells were stratified, they were detached with dispase (400 PU / ml) and washed twice with PBS to prepare individual cell sheets as transplants.
  • the cell sheets were collected from a nude mouse (5-6 weeks old, male, BALB / cnu / nu) under general anesthesia by intraperitoneal administration of Bentbarbi (0.04 mg / g) (Japan (S.L.C., Hamamatsu).
  • the method of transplantation was the method of Barrandon et al. (Barrandon et al., J. Invest. Dermatol., (1998) 91, 315-318) and the method of Sugimura et al. (Sugimura et al., J. cranio-maxillofac Surg., (1997) 24 , 35 2-359).
  • a x30 mm rectangular flap was made to expose the muscular layer.
  • a sterile silicone membrane was placed over the entire exposed mouse muscle layer to isolate the flap from the muscle layer.
  • each of the prepared cell sheets was placed on a sterilized silicone membrane as a carrier for transplantation, and transplanted onto the silicone membrane so that the cells of the sheet were in contact with the inside of the flap.
  • the flap was returned so as to cover the transplanted mucosal epithelial cell sheet and silicone membrane, and the graft was terminated by suturing with a 5-Nail thread.
  • the inner marginal mucosal epithelial cell sheet (mouth) slightly reduced the engraftment rate in about 2 weeks, and maintained the engraftment rate after 3 weeks.
  • the cell sheet (garden) of the oral epithelial cells began to decrease in survival rate after about 12 days, and all died after about 2 weeks. Killing of the epidermal and oral epithelial cell grafts is thought to be due to rejection.
  • the mucosal epithelial cell sheet of the present invention is formed from the oral mucosal epithelial cells, the mucosal epithelial cell sheet can be prepared from the cells in a short time, and the obtained mucosal epithelial cell sheet is obtained.
  • the cell sheet can be used as a graft for a long time.
  • the cell sheet is formed from the oral mucosal epithelial cells adhered to the extracted tooth, the oral mucosal epithelial cells conventionally discarded as biological waste can be effectively used.
  • the gene is transfected into the oral mucosal epithelial cell constituting the present mucosal epithelial cell sheet by ordinary means in the same manner as other mucosal cells, and the oral mucosal epithelial cell sheet into which the desired target gene has been introduced is obtained. Obtainable.
  • Such a gene-introduced oral inner marginal mucosal epithelial cell sheet has various functions depending on the introduced target gene. Can be fulfilled. Industrial applicability
  • the mucosal epithelial cell sheet of the present invention can be prepared more quickly and can be used as an implant that can be engrafted for a long time.
  • various genes can be introduced into the oral mucosal epithelial epithelial cells to form a sheet, so select the target gene, such as a graft with high engraftment efficiency and a carrier for gene therapy. Thus, it can be used as an implant having a desired function.
  • a transplant that can be engrafted for a long period can be prepared more quickly. Further, it is possible to provide a useful method of use for the oral marginal mucosa Ji giant epithelial cells which have been discarded without any special use.
  • the description in this specification is merely for the purpose of describing the present invention and should not be treated as a limitation of the present invention, and various changes may be made without departing from the spirit and scope of the present invention. .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A mucosal epithelial cell sheet consisting of a plural number of layers of oral inner marginal mucosal epithelial cells which adhere to teeth continuously to oral mucosal epithelial cells so as to form a part of the gingival trough. Because of having a potent ability to divide and a low antigenicity, these oral inner marginal mucosal epithelial cells can be prepared within a short time and take over a long period of time.

Description

明 細 書 粘膜上皮細胞シ一ト及びその作製方法 技術分野  Description Mucosal epithelial cell sheet and method for producing the same
本発明は、 粘膜上皮細胞シート及びその作製方法に関し、 特に、 粘膜上皮細胞 が複数の層を形成することによって形成された粘膜上皮細胞シート及びその製造 方法に関する。 景技術  The present invention relates to a mucosal epithelial cell sheet and a method for producing the same, and more particularly to a mucosal epithelial cell sheet formed by forming a plurality of layers of mucosal epithelial cells and a method for producing the same. Landscape technology
ヒトを始めとする生体に、 生きた細胞や組織を移植したり導入したりすること がある。  Living cells and tissues may be transplanted or introduced into living organisms, including humans.
例えば、 創傷包帯としての組織を移植することがある。 この場合、 手術や事故 などによって生体の組織が一部除去された個所が、 除去された部分を補うためや 外観をよくするために、 他の組織 (移植片) で補われる。 このような目的のため に、 様々な移植片が用いられている。  For example, tissue may be implanted as a wound dressing. In this case, the part where the tissue of the living body has been partially removed by surgery or accident is replaced with another tissue (graft) to supplement the removed part or improve the appearance. Various implants have been used for such purposes.
特に、 複数層化した表皮細胞のシートは、 自己の表皮細胞から作製することが できるという利点を有する。 このように作製された表皮細胞シートには、 拒絶反 応が起こることはなく、 このため、 表皮細胞シートは火傷などの場合に有用な移 植片として高く評価されている。  In particular, a multi-layered sheet of epidermal cells has the advantage that it can be prepared from its own epidermal cells. There is no rejection reaction in the epidermal cell sheet thus produced, and therefore, the epidermal cell sheet is highly evaluated as a useful explant for burns and the like.
また、 口腔粘膜細胞から単離された上皮細胞は、 皮膚の角化細胞、 即ち表皮細 胞ょりも未分ィ匕の細胞であるため、 表皮細胞よりも短い代謝サイクルを有してお り、 また角化することなく長期間の維持が可能であるという利点を有する。 この ような性質から、 口腔粘膜細胞は、 表皮角化細胞よりも、 移植用組織として一層 有用であると考えられている。  In addition, epithelial cells isolated from oral mucosal cells have a shorter metabolic cycle than epidermal cells because keratinocytes of the skin, that is, epidermal cells are also unseparated cells. It also has the advantage that it can be maintained for a long period of time without squaring. From these properties, oral mucosal cells are considered to be more useful as tissue for transplantation than epidermal keratinocytes.
しかしながら、 組織を生体に移植する場合、 移植の必要性が生じてから短時間 に移植片を用意する必要がある。 特に、 重度の火傷などの場合には、 移植片の調 製には一刻を争うことがある。 その一方で、 自己の組織から移植片を作製できな い場合に代用された非自己の移植片では、 移植した後で拒絶され、 一旦生着した としてもわずかな期間で排除されてしまう。 However, when transplanting a tissue into a living body, it is necessary to prepare a graft in a short time after the necessity of transplantation. Especially in the case of severe burns, it may take time to prepare the implant. On the other hand, non-self transplants, which were substituted in cases where transplants could not be made from their own tissues, were rejected after transplantation and once survived Even they are eliminated in a short time.
従って、 本発明の目的は、 より迅速に調製することができると共に長期にわた り生着できる移植片を提供することである。  Accordingly, it is an object of the present invention to provide an implant that can be prepared more quickly and that can survive for a longer period.
また、 本発明の目的は、 長期にわたり生着できる移植片をより迅速に調製する ことである。 発明の開示  It is also an object of the present invention to more rapidly prepare a graft that can survive over a long period of time. Disclosure of the invention
本発明の粘膜上皮細胞シートは、 口腔粘膜上皮細胞に連続して歯に付着し、 歯 肉溝の一部を形成する口腔内縁粘膜上皮細胞が、 複数の層を形成することによつ て構成された粘膜上皮細胞シートであることを特徴としている。  The mucosal epithelial cell sheet of the present invention is constituted by forming a plurality of layers of the inner lining mucosal epithelial cells that adhere to the teeth continuously to the oral mucosal epithelial cells and form a part of the gingival sulcus. It is characterized in that it is a treated mucosal epithelial cell sheet.
他の態様において本発明の上記粘膜上皮細胞シートは、 前記口腔内縁粘膜上皮 細胞が、 抜歯の際に歯に付着して歯肉から分離されたものに由来することを特徴 としている。  In another embodiment, the above-mentioned mucosal epithelial cell sheet of the present invention is characterized in that the oral mucosal epithelial cell is derived from one that has adhered to a tooth during tooth extraction and has been separated from gingiva.
また、 本発明の粘膜上皮細胞シートの作製方法は、 口腔粘膜上皮細胞に連続し て歯に付着し、 歯肉溝の一部を形成する口腔内縁粘膜上皮細胞が、 複数の層を形 成することによつて構成された粘膜上皮細胞シートの作製方法であって、 前記口 腔内縁粘膜上皮細胞と、 該口腔内縁粘膜上皮細胞の成育を支持する支持細胞とを 得て、 複数層の前記口腔内縁粘膜上皮細胞で構成された粘膜上皮細胞シ一トを形 成させるために、 前記支持細胞の存在下で前記口腔内縁粘膜上皮細胞を培養し、 形成された粘膜上皮細胞シートを得る、 ことを含む粘膜上皮細胞シ一トの作製方 法であることを特徴としている。  Further, the method for producing a mucosal epithelial cell sheet of the present invention is characterized in that the oral mucosal epithelial cells forming a part of the gingival sulcus, which adhere to the teeth continuously with the oral mucosal epithelial cells, form a plurality of layers. A method for producing a mucosal epithelial cell sheet constituted by the method described above, comprising: obtaining the oral intraoral mucosal epithelial cells; and supporting cells that support the growth of the oral intraoral mucosal epithelial cells; Culturing the oral mucosal epithelial cells in the presence of the supporting cells to obtain a formed mucosal epithelial cell sheet in order to form a mucosal epithelial cell sheet composed of mucosal epithelial cells. The method is characterized by a method for producing a mucosal epithelial cell sheet.
本発明のある態様では、 上記粘膜上皮細胞シートの作製方法は、 前記口腔内縁 粘膜上皮細胞が、 抜歯の際に歯に付着したまま歯肉から分離されたものであるこ とを特徴としている。  In one aspect of the present invention, the method for producing a mucosal epithelial cell sheet is characterized in that the oral rim mucosal epithelial cells are separated from the gingiva while being attached to the teeth during tooth extraction.
また、 本発明の他の態様では、 上記粘膜上皮細胞シートの作製方法は、 前記支 持細胞と前記口腔内縁粘膜上皮細胞との同時培養の前に、 薬剤又は放射線照射に より前記支持細胞の分裂能を消失させることを含むことを特徴としている。 図面の簡単な説明 図 1は、 歯及び歯肉の断面図である。 In another aspect of the present invention, the method for preparing a mucosal epithelial cell sheet comprises dividing the supporting cells by irradiation with a drug or radiation before co-culturing the supporting cells and the oral mucosal epithelial cells. It is characterized in that it includes the loss of performance. BRIEF DESCRIPTION OF THE FIGURES FIG. 1 is a sectional view of a tooth and a gingiva.
図 2は、 口腔内縁粘膜上皮細胞層の位置を示す図 1の部分拡大図である。  FIG. 2 is a partially enlarged view of FIG. 1 showing the position of the oral mucosal epithelial cell layer.
図 3は、 口腔内縁粘膜上皮細胞のコ口ニー形成能を示したグラフである。  FIG. 3 is a graph showing the ability of oral mucosal epithelial cells to form a knee.
図 4は、 口腔内縁粘膜上皮細胞の増殖曲線を示すグラフである。  FIG. 4 is a graph showing the growth curve of the oral mucosal epithelial cells.
図 5は、 口腔内縁粘膜上皮細胞の増殖ァヅセィを示したグラフである。  FIG. 5 is a graph showing the growth of oral mucosal epithelial cells.
図 6 Aは、 口腔粘膜上皮細胞の抗原性を示したグラフ、 図 6 Bは、 口腔内縁粘 膜上皮細胞の抗原性を示したグラフである。  FIG. 6A is a graph showing the antigenicity of oral mucosal epithelial cells, and FIG. 6B is a graph showing the antigenicity of oral rim mucosal epithelial cells.
図 7 Aは、 口腔内縁粘膜上皮細胞から構成された粘膜上皮細胞シ一トの電子顕 微鏡写真、 図 7 Bは、 口腔粘膜上皮細胞から構成された細胞シートの電子顕微鏡 写真、 図 7 Cは、 表皮細胞から構成された細胞シートの電子顕微鏡写真である。 図 8は、 口腔内縁粘膜上皮細胞から形成された粘膜上皮細胞シートの生着率を 示すグラフである。 発明の詳細な説明  Fig. 7A is an electron micrograph of a mucosal epithelial cell sheet composed of oral mucosal epithelial cells, Fig. 7B is an electron micrograph of a cell sheet composed of oral mucosal epithelial cells, Fig. 7C 1 is an electron micrograph of a cell sheet composed of epidermal cells. FIG. 8 is a graph showing the engraftment rate of the mucosal epithelial cell sheet formed from the oral mucosal epithelial cells. Detailed description of the invention
本発明の粘膜上皮細胞シートは、 複数層の口腔内縁粘膜上皮細胞から構成され ている。  The mucosal epithelial cell sheet of the present invention is composed of a plurality of layers of oral mucosal epithelial cells.
口腔内縁粘膜上皮細胞は、 口腔粘膜上皮細胞の 1種である。 図 1及び図 2に示 されるように、 口腔内縁粘膜上皮細胞は、 歯 1 0の下端部を支持する歯肉 1 2の 一部である内縁上皮細胞層 1 4を構成している。 また、 口腔内縁粘膜上皮細胞は、 歯 1 0のエナメル層 1 6表面に付着して、 一般に歯周ポケッ卜と呼ばれる歯肉溝 1 8を形成している。 本明細書では、 この口腔内縁粘膜上皮細胞は、 便宜上、 生 体内での解剖学的な位置で特定される細胞群を意味する。  Oral mucosal epithelial cells are a type of oral mucosal epithelial cells. As shown in FIGS. 1 and 2, the oral mucosal epithelial cells constitute an inner epithelial cell layer 14 which is a part of the gingiva 12 supporting the lower end of the tooth 10. In addition, the oral mucosal epithelial cells adhere to the surface of the enamel layer 16 of the tooth 10 and form a gingival sulcus 18 generally called a periodontal pocket. In the present specification, the oral rim mucosal epithelial cells mean, for convenience, a cell group specified at an anatomical position in a living body.
図 2に示されるように、 歯肉 1 2の上端では、 内縁上皮細胞層 1 4が、 口腔粘 膜細胞層 2 0に連続しており、 歯肉 1 2の内部には、 結合組織部 2 2が配置され ている。 口腔粘膜細胞層 2 0は、 口腔内縁粘膜上皮細胞と異なる口腔粘膜上皮細 胞で構成されている。  As shown in FIG. 2, at the upper end of the gingiva 12, the lining epithelial cell layer 14 is continuous with the oral mucosal cell layer 20, and within the gingiva 12, there is a connective tissue portion 22. It is located. The oral mucosal cell layer 20 is composed of oral mucosal epithelial cells different from the oral mucosal epithelial cells.
本発明者は、 この口腔内縁粘膜上皮細胞が、 歯肉 1 2の外側側面及び口腔内の 他の部位に配置されている口腔粘膜上皮細胞と異なる性質を有することを見出し た。 すなわち、 一般に、 歯肉溝 1 8には、 歯垢が溜まりやすく、 細菌が繁殖しやす いため、 内縁上皮細胞層 1 4の口腔内縁粘膜上皮細胞は、 常に細菌による感染の 危険性に晒されている。 このため、 口腔内縁粘膜上皮細胞は、 同様の粘膜上皮細 胞と異なり、 このような環境に対応できるように特殊化したと思われる。 The present inventor has found that the oral mucosal epithelial cells have different properties from the oral mucosal epithelial cells arranged on the outer side surface of the gingiva 12 and other parts of the oral cavity. In other words, in general, plaque tends to accumulate in the gingival sulcus 18 and bacteria easily proliferate, so the oral lining mucosal epithelial cells in the lining epithelial cell layer 14 are always at risk of bacterial infection . For this reason, it is considered that the oral mucosal epithelial cells are specialized to cope with such an environment, unlike similar mucosal epithelial cells.
特に、 口腔内縁上皮細胞は、 他の部位の口腔粘膜上皮細胞に比べて分裂能が非 常に高いことが見出された。 これは、 細菌の感染や損傷に対抗するためのもので あると思われる。 また、 他の部位の口腔粘膜上皮細胞に比べて抗原性が低いこと も見出された。 すなわち、 口腔内縁粘膜上皮細胞は、 拒絶反応が口腔粘膜上皮細 胞に比べて起こりにくいという利点を有している。  In particular, it was found that the lining epithelial cells of the oral cavity had much higher dividing ability than the oral mucosal epithelial cells of other sites. This seems to be against bacterial infection and damage. It was also found that the antigenicity was lower than that of oral mucosal epithelial cells at other sites. That is, oral mucosal epithelial cells have the advantage that rejection is less likely to occur than oral mucosal epithelial cells.
従って、 本発明の粘膜上皮細胞シートは、 上述したような口腔内縁粘膜上皮細 胞の特性をそのまま備えたものであり、 従来の口腔粘膜上皮細胞シートよりも、 高い分裂能と低い抗原性を有し、 短期間での調製と長期間の生着を実現するもの である。  Therefore, the mucosal epithelial cell sheet of the present invention has the above-mentioned characteristics of the oral marginal mucosal epithelial cell sheet as it is, and has higher division ability and lower antigenicity than the conventional oral mucosal epithelial cell sheet. In addition, it can be prepared in a short period of time and achieve long-term engraftment.
この口腔内縁上皮細胞から構成された内縁上皮細胞層 1 4は、 生体では図 1に 示したように、 歯肉 1 2の口腔粘膜細胞層 2 0に連続して、 歯肉 1 2の上端で内 縁へ陥入し、 歯 1 0側の面で歯 1 0のエナメル層 1 6に付着しているので、 内縁 粘膜上皮細胞は、 内縁上皮細胞層 1 4を歯肉溝 1 8の上端で口腔粘膜細胞層 2 0 から分離させると共にエナメル層 1 6から脱離させることによって、 容易に単離 することができる。  In the living body, the inner epithelial cell layer 14 composed of the oral inner marginal epithelial cells is continuous with the oral mucosal cell layer 20 of the gingiva 12 as shown in FIG. The inner mucosal epithelial cells are attached to the enamel layer 16 of the tooth 10 on the side of the tooth 10, and the inner mucosal epithelial cells are converted to the oral mucosal cells at the upper end of the gingival sulcus 18. It can be easily isolated by separating it from the layer 20 and detaching it from the enamel layer 16.
口腔内縁粘膜上皮細胞を口腔粘膜細胞層 2 0から分離する方法は、 通常の切除 などで行うことができるが、 エナメル層 1 6との付着の程度が口腔粘膜細胞層 2 0及び結合組織との連続性よりも強いため、 歯 1 0を抜歯する際にエナメル層 1 6に付着した状態で口腔粘膜細胞層 2 0及び結合組織部 2 2より分離することが できる。 従って、 抜歯された歯 1 0から容易に回収することができる。  The method of separating the oral mucosal epithelial cells from the oral mucosal cell layer 20 can be performed by ordinary excision, etc., but the degree of adhesion to the enamel layer 16 depends on the degree of adhesion to the oral mucosal cell layer 20 and connective tissue. Since it is stronger than continuity, it can be separated from the oral mucosal cell layer 20 and the connective tissue part 22 while being attached to the enamel layer 16 when the tooth 10 is extracted. Therefore, it can be easily collected from the extracted tooth 10.
多くの場合、 抜歯は歯 1 0における異常/問題が原因で行われるため、 歯 1 0 に付着して回収される口腔内縁粘膜上皮細胞自体は、 細胞の有する特性をそのま ま保持している。 このため、 このような口腔内縁粘膜上皮細胞を使用することが 有利である。  In most cases, tooth extraction is performed due to abnormalities / problems in the tooth 10, so the oral rim mucosal epithelial cells themselves attached to and recovered from the tooth 10 retain the characteristics of the cells as they are . Therefore, it is advantageous to use such oral mucosal epithelial cells.
回収された内縁粘膜上皮細胞に、 例えば結合組織ゃデブリスなどが含まれてい る場合には、 適当な酵素、 例えばデイスパーゼ、 トリプシンなどや、 ナイロンメ ッシュなどを用いて除去することができる。 The collected inner lining mucosal epithelial cells contain, for example, connective tissue ゃ debris. In such cases, the enzyme can be removed using a suitable enzyme such as dispase, trypsin, or nylon mesh.
本発明の粘膜上皮細胞シートは、 口腔内縁粘膜上皮細胞の性質を有するもので あり、 口腔内縁粘膜上皮細胞の構造的特徴も保持している。 例えば、 口腔内縁粘 膜上皮細胞は、 他の部位の口腔粘膜上皮細胞よりも広い細胞間隙を有することが 知られている。 このため、 拡大された細胞間隙に基づいて、 本発明の粘膜上皮細 胞シートを容易に特定することができる。 また、 このような特徴以外の形態は、 他の粘膜細胞シートと同様であり、 粘膜細胞シートを移植できる部位に違和感な く移植できる。  The mucosal epithelial cell sheet of the present invention has properties of oral mucosal epithelial cells, and also retains the structural characteristics of oral mucosal epithelial cells. For example, it is known that oral mucosal epithelial cells have a wider cell gap than oral mucosal epithelial cells at other sites. For this reason, the mucosal epithelial cell sheet of the present invention can be easily specified based on the enlarged cell gap. The form other than these features is the same as other mucosal cell sheets, and can be transplanted to a site where the mucosal cell sheet can be transplanted without a sense of incongruity.
本発明の粘膜上皮細胞シートは、 支持細胞との同時培養により作製される。 支 持細胞には、 例えば線維芽細胞、 例えばマウス N I H 3 T 3細胞、 3 T 3 J 2、 スイス 3 T 3が含まれ、 形成される粘膜上皮細胞シートの厚みや増殖速度の観点 から、 3 T 3 J 2細胞が好ましい。  The mucosal epithelial cell sheet of the present invention is produced by co-culture with a supporting cell. Supporting cells include, for example, fibroblasts, for example, mouse NIH 3T3 cells, 3T3J2, and Swiss 3T3.From the viewpoint of the thickness and growth rate of the formed mucosal epithelial cell sheet, 3 T3J2 cells are preferred.
支持細胞は、 口腔内縁粘膜上皮細胞の成育を干渉しないように増殖能の消失処 理が施されることが好ましい。 増殖能の消失は、 当技術分野において周知の方法、 例えば、 マイ トマイシン Cによる処理や放射線照射によって行うことができる。 また、 培養は、 プラスチックディッシュのような通常の細胞培養容器を用いて行 The supporting cells are preferably subjected to a treatment for eliminating the proliferation ability so as not to interfere with the growth of the oral mucosal epithelial cells. The disappearance of the proliferation ability can be performed by a method well known in the art, for example, treatment with mitomycin C or irradiation. In addition, culture is performed using a normal cell culture vessel such as a plastic dish.
Ό ο Ό ο
口腔内縁粘膜上皮細胞の増殖は、 支持細胞の存在下において行われる。 3 Τ 3 などの支持細胞は、 口腔内縁粘膜上皮細胞よりも先に層を形成するため、 口腔内 縁粘膜上皮細胞と同時に播種しても口腔内縁粘膜上皮細胞は、 支持細胞上で成育 する。 このため、 口腔内縁粘膜上皮細胞は、 増殖時に支持細胞が存在していれば よく、 支持細胞と同時に播種してもよく、 支持細胞が層を形成してからその上に 播種してもよい。  Propagation of the oral mucosal epithelial cells is performed in the presence of supporting cells. Since the supporting cells such as 3Τ3 form layers before the oral mucosal epithelial cells, the oral mucosal epithelial cells grow on the supporting cells even if they are seeded simultaneously with the oral mucosal epithelial cells. Therefore, the oral mucosal epithelial cells may be seeded simultaneously with the supporting cells as long as the supporting cells are present at the time of proliferation, or may be seeded thereon after the supporting cells form a layer.
口腔内縁粘膜上皮細胞は、 1 X 1 0 4個/ c m2以上の細胞密度で播種するこ とができ、 一方、 支持細胞は 1 X 1 0個/ c m2〜l X 1 0 3個/ c m2以上で播 種することができる。 支持細胞が、 これよりも少ないと支持細胞としての役割を 十分に果たすことができないため好ましくない。 また支持細胞は、 口腔内縁粘膜 上皮細胞の成育を支持するためのものであるので、 相当過剰に存在することにな ると却って口腔内縁粘膜上皮細胞の成育の妨げとなるため好ましくない。 口腔内 縁粘膜上皮細胞の細胞数は、 この範囲よりも少ないと効率よく増殖することがで きないため、 好ましくない。 Oral rim mucosal epithelial cells can be seeded at a cell density of 1 × 10 4 cells / cm 2 or higher, while supporting cells are 1 × 10 cells / cm 2 to l × 10 3 cells / cm 2 It can be sowed with two or more. If the number of supporting cells is smaller than this, it is not preferable because it cannot sufficiently serve as a supporting cell. In addition, the supporting cells are used to support the growth of the oral mucosal epithelial epithelial cells. This is not preferred because it hinders the growth of the oral mucosal epithelial cells. If the number of oral mucosal epithelial cells is less than this range, it will not be possible to efficiently proliferate, which is not preferable.
本発明において、 口腔内縁粘膜上皮細胞を支持細胞上で成育させるために成育 培地が用いられる。 この目的に用いられる成育培地には、 当業界で既知の種々の 培地から選択することができる。 成育培地中での培養によって、 口腔内縁粘膜上 皮細胞は容易に複数層を形成する。 一方、 支持細胞は、 粘膜上皮細胞の成育を支 持するのみで死滅し、 粘膜上皮細胞が複数層を形成したときには、 もはや存在し ない。  In the present invention, a growth medium is used for growing oral mucosal epithelial cells on supporting cells. The growth medium used for this purpose can be selected from various media known in the art. By culturing in a growth medium, oral lining mucosal epithelial cells readily form multiple layers. On the other hand, the supporting cells die only by supporting the growth of the mucosal epithelial cells, and are no longer present when the mucosal epithelial cells form multiple layers.
成育培地には、 シート形成能がある上皮シート形成培地 (EFM) を用いるこ とが好ましい。 EFMは、 通常、 表皮細胞を層状に成育させるために用いられて いる培地であり、 DMEMとハム F— 12培地の 3 : 1混合液で構成され、 5% FBS、 5〃g/mlのインシュリン、 5 zg/mlのトランスフェリン、 2 xlO— 9Mのトリヨ一ドサイロニン、 1 xl(T9Mのコレラ毒素、 0.4〃g/ml のハイド口コルチゾン、 10 OU/mlのペニシリン、 0.1 zg/mlのカナ マイシン、 0.25/ g/mlのアンホテリシン B及び 1 Ong/mlのヒト リ コンビナント上皮細胞増殖因子 (EGF) が補充されている。 It is preferable to use an epithelial sheet forming medium (EFM) capable of forming a sheet as the growth medium. EFM is a medium that is usually used to grow epidermal cells in layers. It consists of a 3: 1 mixture of DMEM and Ham's F-12 medium, and contains 5% FBS and 5 μg / ml insulin. Transferrin, 5 zg / ml, 2 xlO— 9 M triiodothyronine, 1 xl (T 9 M cholera toxin, 0.4 μg / ml Hyde mouth cortisone, 10 OU / ml penicillin, 0.1 zg / ml It is supplemented with kanamycin, 0.25 / g / ml amphotericin B and 1 Ong / ml human recombinant epidermal growth factor (EGF).
複数層化した口腔内縁粘膜上皮細胞は、 層構成を維持したまま培養容器から分 離される。 この分離は、 当業界において既知の方法によって行うことができ、 例 えばディスパ一ゼなどの適当な酵素を用いて基底層の接着を阻害することにより 容易に行うことができる。  The multilayered oral mucosal epithelial cells are separated from the culture vessel while maintaining the layer structure. This separation can be performed by methods known in the art, and can be easily performed, for example, by using a suitable enzyme such as dispase to inhibit the adhesion of the basal layer.
得られた粘膜上皮細胞シートは、 当分野において既知の方法により、 生体へ移 植される。 本発明の粘膜上皮細胞シートは、 複数層の口腔内縁粘膜上皮細胞で構 成されているので、 例えばそのまま移植片として移植部位に移植することができ る。 また、 本発明の粘膜上皮細胞シートは、 口腔内、 皮膚下など湿潤環境下にも 移植することにも適しているが、 外界に接している表皮上にも移植することがで きる。 移植は、 口腔内縁粘膜上皮細胞シートに適合した既知の方法をそのまま適 用して実施することができる。  The obtained mucosal epithelial cell sheet is transplanted into a living body by a method known in the art. Since the mucosal epithelial cell sheet of the present invention is composed of a plurality of layers of oral mucosal epithelial cells, it can be transplanted as it is to a transplant site. Further, the mucosal epithelial cell sheet of the present invention is suitable for transplantation in a humid environment such as the oral cavity and under the skin, but can also be transplanted on the epidermis in contact with the outside world. Transplantation can be performed by directly applying a known method adapted to the oral mucosal epithelial cell sheet.
また、 口腔内縁粘膜上皮細胞シートを構成する口腔内縁粘膜上皮細胞には、 他 の粘膜細胞と同様に遺伝子導入を行うことができる。 In addition, the oral mucosal epithelial cells constituting the oral mucosal epithelial cell sheet include: Gene transfer can be performed in the same manner as in the case of the mucosal cells.
遺伝子導入は、 導入の対象となる遺伝子 (対象遺伝子) を慣用の方法により導 入することによって容易に行うことができる。 口腔内縁粘膜上皮細胞は、 表皮細 胞のような成熟細胞よりも未分化の細胞であるので、 成熟細胞よりも容易に遺伝 子導入できる。  Gene transfer can be easily performed by introducing a gene to be transferred (target gene) by a conventional method. Since oral mucosal epithelial cells are more undifferentiated than mature cells such as epidermal cells, genes can be introduced more easily than mature cells.
対象遺伝子には、 移植片の生着効率を高めるために有用な因子、 例えば、 抗生 物質及び抗菌ペプチド (デュフェンシンなど) のような移植片の生着時における 細菌感染を阻止するための因子並びに、 血小板成長因子 (PDGF)、 繊維芽細 胞成長因子 (FGF)及び肝細胞成長因子 (HFG)のような移植片の生着を促 進する因子が含まれる。 これらの遺伝子は、 文献等において公知であると共に公 的機関などから容易に入手可能である。  Genes of interest include factors useful for increasing graft engraftment efficiency, such as antibiotics and antimicrobial peptides (such as dufensin) to prevent bacterial infection during graft engraftment, Includes factors that promote graft survival, such as platelet growth factor (PDGF), fibroblast growth factor (FGF), and hepatocyte growth factor (HFG). These genes are known in the literature and can be easily obtained from public institutions and the like.
また、 遺伝子治療のための遺伝子を対象遺伝子とすることができる。 このよう な遺伝子治療の対象となり得る対象遺伝子には、 先天的 ·後天的欠損因子、 例え ば血液凝固因子、 インシュリン、 各種成長因子、 癌抑制遺伝子、 腫瘍抗原遺伝子 などが含まれる。 これらの遺伝子も前記同様に、 容易に入手可能である。 実施例  In addition, a gene for gene therapy can be a target gene. Target genes that can be targeted for such gene therapy include congenital and acquired deficiency factors, such as blood coagulation factors, insulin, various growth factors, tumor suppressor genes, and tumor antigen genes. These genes are easily available as described above. Example
以下に本発明を代表する実施例を説明する。  Hereinafter, examples representing the present invention will be described.
I. 口腔内縁粘膜上皮細胞の回収 I. Recovery of oral mucosal epithelial cells
口腔内縁粘膜上皮細胞は、 親知らずの抜歯を目的として病院に来た患者の了解 を得て、 抜歯処理後の歯から回収された。 口腔内縁粘膜上皮層は、 抜歯の際に、 歯肉の上端部分で引きちぎられており、 これにより、 他の部位の口腔粘膜上皮細 胞から分離されていた。 抜歯はできるだけ無菌的に行い、 抜歯された歯に付着し ている口腔内縁粘膜上皮層を、 丁寧に歯のエナメルセメント移行部より分離した。 口腔内縁粘膜上皮層を、 100 OU/mlのペニシリン(Sigma, St. Louis, M 0)、 lmg/mlのカナマイシン及び 2. のアンホテリシン B(Gibco, Gla nd Island, NY)を含有するリン酸緩衝液 (PBS)で、 30分間37 で2回浸 潰した。 組織をそれから 100 OPU/mlのデイスパーゼ (登録商標) (合同酒 精株式会社製) を含有するダルベッコ改変最小必須培地 (DMEM) に 16時間 4°Cで浸漬し、 その後、 30分間室温で 0.25%トリプシン(Gibco, Gland Isl and,NY)で処理して、 細胞を分離させた。 酵素活性は、 10%ゥシ胎児血清 (F BS) (Hyclone, UT)を含有する DMEMで洗浄することにより停止させた。 そ の後、 10%FBSを含有する DMEMで 30分間攪拌してから、 50〃mのナ ィロンガーゼでデブリスをろ過して、 口腔内縁粘膜上皮細胞を単離した。 Oral rim mucosal epithelial cells were recovered from the tooth after the tooth extraction process with the consent of a patient who came to the hospital for the purpose of wisdom tooth extraction. The oral mucosal epithelial layer was torn off at the upper end of the gingiva during tooth extraction, and thus was separated from the oral mucosal epithelial cells at other sites. The tooth extraction was performed as aseptically as possible, and the oral mucosal epithelial layer adhering to the extracted tooth was carefully separated from the tooth enamel cement transition. The oral mucosal epithelial layer was washed with a phosphate buffer containing 100 OU / ml penicillin (Sigma, St. Louis, Mo.), lmg / ml kanamycin and 2. amphotericin B (Gibco, Gland Island, NY). The solution was immersed twice in PBS (PBS) at 37 for 30 minutes. The tissue is then placed in Dulbecco's Modified Minimum Essential Medium (DMEM) containing 100 OPU / ml Dispase® (manufactured by Godo Shusei Co., Ltd.) for 16 hours. The cells were immersed at 4 ° C and then treated with 0.25% trypsin (Gibco, Gland Isl and NY) for 30 minutes at room temperature to separate the cells. Enzyme activity was stopped by washing with DMEM containing 10% fetal calf serum (FBS) (Hyclone, UT). Thereafter, the mixture was stirred in DMEM containing 10% FBS for 30 minutes, and then the debris was filtered with a 50 μm nylon gauze to isolate the oral mucosal epithelial cells.
II. 口腔内縁粘膜上皮細胞の特性 II. Characteristics of oral mucosal epithelial cells
(1) シート形成能  (1) Sheet forming ability
口腔内縁粘膜上皮細胞の増殖活性を確認するために、 上述の口腔内縁粘膜上皮 細胞 (以下、 内縁上皮細胞とする) と、 口腔内の他の部位の粘膜上皮細胞 (以下、 口腔上皮細胞とする) と、 表皮細胞とのコロニー形成能及び増殖速度を測定した。 口腔上皮細胞は、 ヒトの口腔内の歯槽歯肉堤粘膜から単離した。 また表皮細胞は、 ヒ卜の腹部の皮膚から単離した。  In order to confirm the proliferation activity of the oral mucosal epithelial cells, the above-mentioned oral mucosal epithelial cells (hereinafter referred to as inner epithelial cells) and the mucosal epithelial cells at other parts of the oral cavity (hereinafter referred to as oral epithelial cells) ) And the ability to form colonies with epidermal cells and the growth rate were measured. Oral epithelial cells were isolated from the human alveolar gingival mucosa in the oral cavity. Epidermal cells were also isolated from human abdominal skin.
コロニー形成能アツセィは、 既知の方法により行った。 簡単に説明すれば、 以 下の通りである。 25 cm2の T型フラスコ (Nunc社製) に、 内縁上皮細胞、 口 腔上皮細胞及び表皮細胞をそれそれ 1 X 103個ずつ播種し、 培養 5日後に、 メ チレンブルー (SIGMA社製) で染色した。 コロニーの数は、 染色のものを肉眼で 計測した。 結果を図 3に示す。 The colony forming ability was determined by a known method. Briefly, it is as follows. Into a 25 cm 2 T-type flask (Nunc), inoculate 1 × 10 3 limbal epithelial cells, oral epithelial cells and epidermal cells, and after 5 days of culture, use methylene blue (SIGMA). Stained. The number of colonies was determined by visual inspection of the stained ones. The results are shown in Figure 3.
増殖速度は、 細胞数による計測方法と、 MTTアツセィにより行った。 細胞数 による計測方法は、 へモサイ トメ一夕一を用いて、 細胞数を直接計測した。 MT Tアツセィは、 MTT (3— (4, 5—ジメチルチオゾ一ル—2—ィル) —2, 5—ジフエニルテトラゾリゥムブ口マイ ド) (SIGMA社製) の色素変化を利用し た方法である。 MTTは、 帯黄色の化合物であるが、 生細胞の活動性ミトコンド リアにより分解されて、 暗青色のフオルマザン化合物を生じる。 このため、 この 色素により生きた細胞のみを染色し、 相対的な細胞量を簡便に計測した。 結果を それそれ図 4及び図 5に示す。  The growth rate was measured by a cell count method and MTT assay. The cell number was directly measured using a hemocytometer overnight. MTT Atsee utilizes the color change of MTT (3- (4,5-dimethylthiozol-2-yl) -2,5-diphenyltetrazoliumbutamate) (manufactured by SIGMA). Is the way. MTT is a yellowish compound that is degraded by the active mitochondria of living cells to produce a dark blue formazan compound. For this reason, only living cells were stained with this dye, and the relative cell amount was simply measured. The results are shown in FIGS. 4 and 5, respectively.
コロニー形成能は、 細胞の有する増殖ポテンシャルを示すものである。 図 3に 示されるように、 内縁上皮細胞のコロニー形成能は、 表皮細胞の約 2倍であり、 口腔上皮細胞に対しても有意に高いことが示された。 また、 内縁上皮細胞の増殖 速度は、 表皮細胞及び口腔上皮細胞よりも速いことが示された (図 4及び図 5参 BH、、 n The colony forming ability indicates the growth potential of the cell. As shown in FIG. 3, the colony forming ability of the limbal epithelial cells was about twice that of the epidermal cells, and was significantly higher than that of the oral epithelial cells. In addition, it was shown that the proliferation rate of inner epithelial cells was faster than that of epidermal cells and oral epithelial cells (see FIGS. 4 and 5). BH ,, n
これらの結果から、 内縁上皮細胞は、 高い増殖能を有するという特徴を持ち、 口腔上皮細胞とは明らかに異なる細胞群であり、 細胞シ一トの形成をする場合、 より迅速にシートを形成できる、 すなわちシート形成能が高いことが示唆される。 Based on these results, lining epithelial cells have the characteristic of having a high proliferative capacity, and are a distinctly different cell group from oral epithelial cells, and can form sheets more rapidly when forming cell sheets. That is, it is suggested that the sheet forming ability is high.
( 2 ) 腿生 (2) Thigh
次に、 口腔内縁粘膜上皮細胞シートの抗原性について調べた。 抗原性は、 内縁 上皮細胞と口腔上皮細胞の双方における I A抗原及び Thy— 1抗原の発現のァ ッセィにより測定した。 アツセィ方法は、 以下の通りである。  Next, the antigenicity of the oral mucosal epithelial cell sheet was examined. Antigenicity was determined by assay of the expression of IA and Thy-1 antigens on both limbal and oral epithelial cells. Atsey's method is as follows.
上述した方法にしたがって、 5— 6週齢の雄のマウス (BALB/c、 IA = d、 日本エス ·エル ·シ一、 浜松) から内縁上皮細胞及び表皮細胞を得た。 また、 同様にして、 同週齢の雄マウス (C3H/Hen、 I A = k) から口腔上皮細胞 及び表皮細胞を得た。 単離された BALB/cマウスの細胞に抗 I Ad抗体 (Ce clarlane社製) を、 C 3 H/H e nマウス細胞に抗 I Ak抗体 (Becton Dickins on社製) を、 それそれ 1/25の濃度で加え、 4°C60分インキュベートしてか ら、 次いでラビット補体を加えて 37°C60分間培養した。 培養開始前、 培養 3, 5, 7日目に、 それぞれ細胞を回収し、 FITC結合抗 MHCクラス I I抗体 (B ecton Dickinson社製) を 1/300の濃度で加えて 4 °C 45分間ィンキュベ一 トした後、 蛍光顕微鏡で観察した。 次いで、 I A抗原陽性細胞及び Thy— 1抗 原陽性細胞 (樹状細胞) の数を、 フローサイ トメトリ一を用いて測定した。 結果 を図 6に示す。 In accordance with the method described above, limbal epithelial cells and epidermal cells were obtained from 5-6 week old male mice (BALB / c, IA = d, Nippon S.L.C., Hamamatsu). Similarly, oral epithelial cells and epidermal cells were obtained from male mice of the same age (C3H / Hen, IA = k). Anti-IA d antibody (Ce clarlane) was applied to the isolated BALB / c mouse cells, and anti-IA k antibody (Becton Dickins on) was applied to C 3 H / Hen mouse cells. After incubation at 4 ° C for 60 minutes, rabbit complement was added, followed by incubation at 37 ° C for 60 minutes. Before the start of the culture, on the third, fifth and seventh days of the culture, the cells are collected, and FITC-conjugated anti-MHC class II antibody (Becton Dickinson) is added at a concentration of 1/300, and the mixture is incubated at 4 ° C for 45 minutes. After that, the cells were observed with a fluorescence microscope. Next, the numbers of IA antigen-positive cells and Thy-1 antigen-positive cells (dendritic cells) were measured using flow cytometry. Figure 6 shows the results.
図 6に示されるように、 内縁上皮細胞における Thy— 1抗原及び I A抗原の 発現は、 共に培養期間の経過に従って低下していた。 この IAfc¾は、 内縁上皮 細胞中の免疫担当細胞、 ランゲルハンス細胞上に発現されていると思われる。 内 縁上皮細胞では、 このように、 細胞抗原となる ΙΑί¾及び Thy— 1¾¾の発 現が共に経時的低下していることから、 培養期間の経過と共に免疫応答が弱くな ることが示唆された。  As shown in FIG. 6, the expression of Thy-1 antigen and IA antigen in the limbal epithelial cells both decreased with the lapse of the culture period. This IAfc¾ is considered to be expressed on immunocompetent cells, Langerhans cells, in limbal epithelial cells. In the limbal epithelial cells, the expression of both cell antigens ΙΑί¾ and Thy-1 共 に declined with time, suggesting that the immune response became weaker with the passage of the culture period.
一方、 口腔上皮細胞における Thy— 1抗原の発現は、 I A抗原の発現とは異 なり、 培養期間が経過しても低下しないことが示された。 このため、 口腔上皮細 胞は、 内縁上皮細胞よりも細胞抗原量の低下が認められず、 培養期間が経過して も内縁上皮細胞ほど、 免疫応答の縮小化が認められないことが示唆される。 On the other hand, Thy-1 antigen expression in oral epithelial cells was different from IA antigen expression, and was shown not to decrease even after the culture period. For this reason, oral epithelial cells did not show a decrease in the amount of cellular antigens compared to inner epithelial cells, and after the culture period This suggests that the immune response is not reduced as much as in the limbal epithelial cells.
これらのことから、 内縁上皮細胞は、 ί¾ 性が低いという特徴を有することで 口腔上皮細胞とは異なる細胞群であり、 移植させても拒絶反応が起こりにくい細 胞シートを形成できることが示唆された。  These facts suggest that limbal epithelial cells are a group of cells different from oral epithelial cells due to their low aggressiveness and can form cell sheets that are unlikely to undergo rejection even when transplanted. .
III. 粘膜上皮細胞シートの形成  III. Formation of mucosal epithelial cell sheet
( 1 ) 支持細胞の調製  (1) Preparation of feeder cells
支持細胞としての 3 Τ 3— J 2細胞を、 血清を含有しない DMEM中 4 g/ mlのマイ トマイシン C (協和醜酵、 東京) で処理した。 2時間後に、 PBS (―) で数回リンスしてマイトマイシン Cを除去し、 トリプシン処理した後、 1 X 104個/ cm2の細胞密度で播種できるように、 細胞懸濁液を調製した。 3Τ3-J2 cells as feeder cells were treated with 4 g / ml mitomycin C (Kyowa Ugly, Tokyo) in serum-free DMEM. After 2 hours, PBS (-) was rinsed several times to remove mitomycin C, after trypsinization, so that it can be seeded at a density of 1 X 10 4 cells / cm 2, to prepare a cell suspension.
(2) シートの形成  (2) Sheet formation
1 X 104個/ cm2の細胞密度で播種できるように調整された口腔内縁粘膜 上皮細胞の懸濁液と、 1 X 104個/ cm 2の細胞密度で播種できるように調整 された支持細胞の懸濁液とを、 35 mmディッシュに 1 m 1ずつ添加して、 E F M培地中で培養した。 2— 3日毎に培地を、 新鮮な上記 EFM選択培地と交換し た。 支持細胞上に播種して培養した口腔内縁粘膜上皮細胞は、 支持細胞上での約 10日ほどの培養により、 使用可能な粘膜細胞シートとして十分な厚さ (3〜5 層、 100 Π1程度) になった。 一方、 支持細胞は、 増殖能が消失しているので、 口腔内縁粘膜上皮細胞の培養期間中で死滅し、 粘膜上皮細胞シートが形成される ときには、 培養系から除去されていた。 形成された粘膜上皮細胞シートは、 口腔 内縁粘膜上皮細胞から構成されており、 この粘膜上皮細胞シートを使用する際に は、 上皮細胞シートを、 ディスパ一ゼ (400PU/ml)でディッシュから剥 離し、 PBSで 2回洗浄した。 1 and suspensions adjusted oral inner mucosal epithelial cells as X 10 may seeded 4 / cm 2 in the cell density was adjusted to allow seeding at a cell density of 1 X 10 4 / cm 2 supported The cell suspension was added to a 35 mm dish in an amount of 1 ml, and cultured in an EFM medium. Every 2-3 days, the medium was replaced with fresh EFM selective medium. Oral mucosal epithelial cells seeded and cultured on supporting cells can be used as a mucosal cell sheet that can be used by culturing on supporting cells for about 10 days (three to five layers, about 100Π1) Became. On the other hand, since the supporting cells have lost their proliferative ability, they died during the culture period of the oral mucosal epithelial cells, and were removed from the culture system when the mucosal epithelial cell sheet was formed. The formed mucosal epithelial cell sheet is composed of oral and inner lining mucosal epithelial cells. When using this mucosal epithelial cell sheet, the epithelial cell sheet is detached from the dish with dispase (400 PU / ml). Washed twice with PBS.
IV. 粘膜上皮細胞シートの性質  IV. Properties of mucosal epithelial cell sheet
( 1 ) 粘膜上皮細胞シートの形成能  (1) Ability to form mucosal epithelial cell sheet
上述のようにして形成された内縁上皮細胞の粘膜上皮細胞シートは、 約 10日 の培養により、 移植片として使用可能な状態になることができた。 これに対して、 口腔上皮細胞シートは、 約 2週間程度の培養時間を必要とする。 このことから、 内縁上皮細胞シートは、 口腔上皮細胞シートよりも早期に使用可能な移植片であ ることが示された。 The mucosal epithelial cell sheet of limbal epithelial cells formed as described above was able to be used as a graft after culturing for about 10 days. On the other hand, the oral epithelial cell sheet requires about 2 weeks of culture time. Therefore, the lining epithelial cell sheet is a graft that can be used earlier than the oral epithelial cell sheet. Rukoto has been shown.
( 2 ) 粘膜上皮細胞シートの形態的特性  (2) Morphological characteristics of mucosal epithelial cell sheet
次に、 内縁上皮細胞と口腔上皮細胞との細胞シートにおける形態的な相違を調 ベるために、 電子顕微鏡により観察した。 内縁上皮細胞シート及び口腔上皮細胞 シートと、 表皮細胞シートとを、 それそれ上述したようにして形成し、 力ルノフ スキ固定液で 2時間固定し、 薄切後、 透過型電子顕微鏡にて撮影した。 結果を図 7 A、 図 7 B及び図 7 Cに示す。  Next, in order to examine the morphological differences in the cell sheet between the lining epithelial cells and the oral epithelial cells, the cells were observed with an electron microscope. Inner marginal epithelial cell sheet, oral epithelial cell sheet, and epidermal cell sheet were each formed as described above, fixed with a Kernovski fixative for 2 hours, sliced, and photographed with a transmission electron microscope. . The results are shown in FIGS. 7A, 7B and 7C.
図 7 Aに示されるように、 内縁上皮細胞から構成された粘膜上皮細胞シ一トは、 表皮細胞シート (図 7 C ) とは明らかに異なる形態を示している。 また、 口腔上 皮細胞から構成された粘膜上皮細胞シート (図 7 B ) と比較すると、 内縁上皮細 胞から構成された粘膜上皮細胞シートの方が広い細胞間隙を有することが示され た。  As shown in FIG. 7A, the mucosal epithelial cell sheet composed of the limbal epithelial cells has a clearly different morphology from the epidermal cell sheet (FIG. 7C). In addition, compared with the mucosal epithelial cell sheet composed of oral epidermal cells (FIG. 7B), it was shown that the mucosal epithelial cell sheet composed of the inner peripheral epithelial cells had a wider cell gap.
このような広い細胞間隙は、 内縁上皮細胞の特有の性質であり、 内縁上皮細胞 から構成された粘膜上皮細胞シートにも保持されていることが示された。 また、 このような形態的な特性に基づいて、 内縁上皮細胞から構成された粘膜上皮細胞 シートを特定できることも確認された。  Such a wide intercellular space was a characteristic property of the limbal epithelial cells, and was shown to be retained in the mucosal epithelial cell sheet composed of the limbal epithelial cells. It was also confirmed that a mucosal epithelial cell sheet composed of limbal epithelial cells could be identified based on such morphological characteristics.
( 3 ) 粘膜上皮細胞シ一トの抗原性  (3) Antigenicity of mucosal epithelial cell sheets
粘膜上皮細胞シートの抗原性を調べるために、 マウスの細胞を用いて生着アツ セィを行った。 上述した方法と同様の方法により、 内縁上皮細胞、 口腔上皮細胞 及び表皮細胞を採取して、 所定期間の培養により重層化させた。 それそれの細胞 が重層化したら、 ディスパ一ゼ (4 0 0 P U/m l ) で剥離し、 P B Sで 2回洗 浄することによって、 移植片としてのそれそれの細胞シートを用意した。 それそ れの細胞シ一トは、 ベントバルビ夕一ル 0 . 0 4 m g/gの腹腔内投与による全 身麻酔下のヌードマウス (5— 6週齢、 雄、 B A L B/ c n u/n u) (日本ェ スエルシー株式会社、 浜松) に移植した。  In order to examine the antigenicity of the mucosal epithelial cell sheet, engraftment was performed using mouse cells. By the same method as described above, lining epithelial cells, oral epithelial cells, and epidermal cells were collected and layered by culturing for a predetermined period. Once the cells were stratified, they were detached with dispase (400 PU / ml) and washed twice with PBS to prepare individual cell sheets as transplants. The cell sheets were collected from a nude mouse (5-6 weeks old, male, BALB / cnu / nu) under general anesthesia by intraperitoneal administration of Bentbarbi (0.04 mg / g) (Japan (S.L.C., Hamamatsu).
移植方法は、 Barrandonらの方法(Barrandonら、 J. Invest. Dermatol. , ( 1998) 9 1, 315-318)及び杉村らの方法 (杉村ら、 J. cranio-maxillofac Surg. , (1997)24, 35 2-359)に基づいて行った。  The method of transplantation was the method of Barrandon et al. (Barrandon et al., J. Invest. Dermatol., (1998) 91, 315-318) and the method of Sugimura et al. (Sugimura et al., J. cranio-maxillofac Surg., (1997) 24 , 35 2-359).
すなわち、 マウス背部を 1 0 %ヒビテンアルコールで十分に消毒した後、 3 0 x 3 0 mmの矩形の皮弁を作製し、 筋層を露出させた。 露出したマウス筋層の 全面に、 滅菌したシリコーン膜を載置して、 皮弁と筋層とを隔離した。 次に作製 したそれそれの細胞シートを、 移植キヤリアとしての滅菌したシリコーン膜に配 置し、 シートの細胞が皮弁内側と接するようにシリコーン膜上に移植した。 それ から、 移植した粘膜上皮細胞シート及びシリコーン膜を覆うように皮弁を戻し、 5—ナイ口ン糸で縫合して移植を終了した。 That is, after thoroughly disinfecting the back of the mouse with 10% A x30 mm rectangular flap was made to expose the muscular layer. A sterile silicone membrane was placed over the entire exposed mouse muscle layer to isolate the flap from the muscle layer. Next, each of the prepared cell sheets was placed on a sterilized silicone membrane as a carrier for transplantation, and transplanted onto the silicone membrane so that the cells of the sheet were in contact with the inside of the flap. Then, the flap was returned so as to cover the transplanted mucosal epithelial cell sheet and silicone membrane, and the graft was terminated by suturing with a 5-Nail thread.
移植 3日目より、 3日毎に、 皮弁を再挙上し、 それそれの細胞シート移植部を 肉眼的に観察した。 白化して剥離してきた細胞は、 生着できずに死滅していると 判断した。 生着率は、 移植面に対する生着細胞の面積の比率から算出した。 結果 を図 8に示す。  From the third day of transplantation, the flap was raised again every three days, and each cell sheet transplant was visually observed. Cells that were whitened and detached were judged to be dead because they could not survive. The engraftment rate was calculated from the ratio of the area of the engrafted cells to the transplanted surface. Figure 8 shows the results.
図 8に示されるように、 内縁粘膜上皮細胞シート (口) は、 約 2週間で生着率 がわずかに低下するもの、 その後 3週間を経過しても生着率を維持していた。 こ れに対して、 表皮細胞の細胞シート (△) は移植後約 1 0日でほぼ全ての細胞が 死滅した。 また、 口腔上皮細胞の細胞シート (園) は 1 2日を経過した頃より生 着率が低下し始め、 約 2週間を経過すると共に全て死滅した。 表皮細胞及び口腔 上皮細胞の移植片の死滅は、 拒絶反応によるものと考えられる。  As shown in Fig. 8, the inner marginal mucosal epithelial cell sheet (mouth) slightly reduced the engraftment rate in about 2 weeks, and maintained the engraftment rate after 3 weeks. In contrast, almost all cells of the epidermal cell sheet (△) died about 10 days after transplantation. In addition, the cell sheet (garden) of the oral epithelial cells began to decrease in survival rate after about 12 days, and all died after about 2 weeks. Killing of the epidermal and oral epithelial cell grafts is thought to be due to rejection.
内縁粘膜上皮細胞の細胞シートの高い生着率の維持は、 内縁粘膜上皮細胞にお ける T h y— 1抗原の発現の低下 (図 6参照) と関係があるものと考えられる。 以上にように、 本発明の粘膜上皮細胞シートは、 口腔内縁粘膜上皮細胞から形 成されているので、 細胞から短時間で粘膜上皮細胞シートを調製することができ ると共に、 得られた粘膜上皮細胞シートは長期にわたって移植片として使用する ことができる。  It is thought that the maintenance of a high cell sheet engraftment rate of inner mucosal epithelial cells is related to a decrease in the expression of Thy-1 antigen in inner mucosal epithelial cells (see Fig. 6). As described above, since the mucosal epithelial cell sheet of the present invention is formed from the oral mucosal epithelial cells, the mucosal epithelial cell sheet can be prepared from the cells in a short time, and the obtained mucosal epithelial cell sheet is obtained. The cell sheet can be used as a graft for a long time.
また、 抜歯された歯に付着した口腔内縁粘膜上皮細胞から細胞シートを形成す るので、 従来、 生体廃棄物として廃棄されていた口腔内縁粘膜上皮細胞を有効利 用することができる。  In addition, since the cell sheet is formed from the oral mucosal epithelial cells adhered to the extracted tooth, the oral mucosal epithelial cells conventionally discarded as biological waste can be effectively used.
更に、 本粘膜上皮細胞シートを構成する口腔内縁粘膜上皮細胞に対して、 他の 粘膜細胞と同様に通常の手段によって遺伝子導入を行い、 所望する対象遺伝子が 導入された口腔内縁粘膜上皮細胞シートを得ることができる。 このような遺伝子 導入口腔内縁粘膜上皮細胞シートは、 導入された対象遺伝子に応じた種々の機能 を果たすことができる。 産業上の利用可能性 Furthermore, the gene is transfected into the oral mucosal epithelial cell constituting the present mucosal epithelial cell sheet by ordinary means in the same manner as other mucosal cells, and the oral mucosal epithelial cell sheet into which the desired target gene has been introduced is obtained. Obtainable. Such a gene-introduced oral inner marginal mucosal epithelial cell sheet has various functions depending on the introduced target gene. Can be fulfilled. Industrial applicability
本発明の粘膜上皮細胞シ一トは、 より迅速に調製することができると共に長期 にわたり生着できる移植片として用いることができる。  The mucosal epithelial cell sheet of the present invention can be prepared more quickly and can be used as an implant that can be engrafted for a long time.
またこれに加えて、 口腔内縁粘膜上皮細胞に種々の遺伝子を導入してシートを 形成させることができるので、 生着効率の高い移植片ゃ遺伝子治療用のキヤリア のように、 対象遺伝子を選択することにより所望する機能を有する移植片として 利用することができる。  In addition, various genes can be introduced into the oral mucosal epithelial epithelial cells to form a sheet, so select the target gene, such as a graft with high engraftment efficiency and a carrier for gene therapy. Thus, it can be used as an implant having a desired function.
本発明の粘膜上皮細胞シートの作製方法により、 長期にわたり生着できる移植 片をより迅速に調製することができる。 また、 従来、 特別な利用用途がなく廃棄 されていた口腔内縁粘 Ji莫上皮細胞に対して有用な利用方法を提供することができ る。 本明細書の記載は、 単に本発明の説明を目的とするものであって本発明の制限 として取り扱われるべきではなく、 種々の変更が本発明の精神及び範囲を逸脱す ることなく可能である。  By the method for producing a mucosal epithelial cell sheet of the present invention, a transplant that can be engrafted for a long period can be prepared more quickly. Further, it is possible to provide a useful method of use for the oral marginal mucosa Ji giant epithelial cells which have been discarded without any special use. The description in this specification is merely for the purpose of describing the present invention and should not be treated as a limitation of the present invention, and various changes may be made without departing from the spirit and scope of the present invention. .

Claims

請求の範囲 The scope of the claims
1 . 口腔粘膜上皮細胞に連続して歯に付着し、 歯肉溝の一部を形成する 口腔内縁粘膜上皮細胞が、 複数の層を形成することによって構成された粘膜上皮 細胞シート。 1. A mucosal epithelial cell sheet composed of multiple layers of oral mucosal epithelial cells forming a part of the gingival sulcus, which are continuously attached to the oral mucosal epithelial cells and form a part of the gingival sulcus.
2 . 前記口腔内縁粘膜上皮細胞は、 抜歯の際に歯に付着して歯肉から分 離されたものに由来する請求の範囲第 1項に記載の粘膜上皮細胞シート。 2. The mucosal epithelial cell sheet according to claim 1, wherein said oral mucosal epithelial cells are derived from those adhered to teeth and separated from gingiva during tooth extraction.
3 . 口腔粘膜上皮細胞に連続して歯に付着し、 歯肉溝の一部を形成する 口腔内縁粘膜上皮細胞が、 複数の層を形成することによって構成された粘膜上皮 細胞シートの作製方法であって、 3. A method for producing a mucosal epithelial cell sheet comprising a plurality of layers of oral mucosal epithelial cells forming a part of the gingival sulcus, which are continuously attached to the oral mucosal epithelial cells and form a part of the gingival sulcus. hand,
前記口腔内縁粘膜上皮細胞と、 該口腔内縁粘膜上皮細胞の成育を支持する支持 細胞とを得て、  Obtaining the oral mucosal epithelial cells and supporting cells that support the growth of the oral mucosal epithelial cells,
複数層の前記口腔内縁粘膜上皮細胞で構成された粘膜上皮細胞シ一トを形成さ せるために、 前記支持細胞の存在下で前記口腔内縁粘膜上皮細胞を培養し、 形成された粘膜上皮細胞シートを得る、  A mucosal epithelial cell sheet formed by culturing the oral mucosal epithelial cells in the presence of the supporting cells to form a mucosal epithelial cell sheet composed of a plurality of layers of the oral mucosal epithelial cells; Get
ことを含む粘膜上皮細胞シートの作製方法。 A method for producing a mucosal epithelial cell sheet comprising:
4 . 前記口腔内縁粘膜上皮細胞は、 抜歯の際に歯に付着したまま歯肉か ら分離されたものであることを特徴とする請求の範囲第 3項に記載の粘膜上皮細 胞シートの作製方法。 4. The method for producing a mucosal epithelial cell sheet according to claim 3, wherein the oral inner marginal mucosal epithelial cells are separated from the gingiva while being attached to the teeth during tooth extraction. .
5 . 前記支持細胞と前記口腔内縁粘膜上皮細胞との同時培養の前に、 薬 剤又は放射線照射により前記支持細胞の分裂能を消失させることを含む請求の範 囲第 3項又は第 4項に記載の粘膜上皮細胞シ一トの作製方法。 5. The method according to claim 3, wherein the method further comprises, prior to the simultaneous culture of the supporting cells and the oral mucosal epithelial cells, eliminating the dividing ability of the supporting cells by irradiation with a drug or radiation. A method for producing the mucosal epithelial cell sheet according to the above.
PCT/JP1999/006517 1998-11-26 1999-11-22 Mucosal epithelial cell sheet and method for producing the same WO2000030695A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU11860/00A AU1186000A (en) 1998-11-26 1999-11-22 Mucosal epithelial cell sheet and method for producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10/336397 1998-11-26
JP10336397A JP3043727B1 (en) 1998-11-26 1998-11-26 Mucosal epithelial cell sheet

Publications (1)

Publication Number Publication Date
WO2000030695A1 true WO2000030695A1 (en) 2000-06-02

Family

ID=18298721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/006517 WO2000030695A1 (en) 1998-11-26 1999-11-22 Mucosal epithelial cell sheet and method for producing the same

Country Status (3)

Country Link
JP (1) JP3043727B1 (en)
AU (1) AU1186000A (en)
WO (1) WO2000030695A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916655B2 (en) 2001-11-22 2005-07-12 Nipro Corporation Cultured skin and method of manufacturing the same
US7497686B2 (en) 2004-09-02 2009-03-03 Odontis Ltd. Bone regeneration

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4745525B2 (en) * 2001-05-09 2011-08-10 実 上田 Cultured epithelial cell sheet for corneal treatment and method for producing the same
JP5786432B2 (en) * 2011-04-28 2015-09-30 株式会社 ジャパン・ティッシュ・エンジニアリング Manufacturing schedule management system for regenerative medical products

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012510A1 (en) * 1994-10-25 1996-05-02 Boehringer Mannheim Gmbh Biomaterial containing epithelial cells and use thereof as a transplant
JPH10277143A (en) * 1997-04-08 1998-10-20 Tokai Univ Transplant and manufacture of the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012510A1 (en) * 1994-10-25 1996-05-02 Boehringer Mannheim Gmbh Biomaterial containing epithelial cells and use thereof as a transplant
JPH10277143A (en) * 1997-04-08 1998-10-20 Tokai Univ Transplant and manufacture of the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HATA K. ET AL.: "The characteristics of cultured mucosal cell sheet as a material for grafting; Comparison with cultured epidermal cell sheet", ANNALS OF PLASTIC SURGERY,, vol. 34, no. 5, 1995, pages 530 - 538, XP002927611 *
UEDA M. ET AL.: "The potential of oral mucosal cells for cultured epithelium: A preliminary report", ANNALS OF PLASTIC SURGERY,, vol. 35, no. 5, 1995, pages 498 - 504, XP002927610 *
UEDA M.: "Formation of epithelial sheets by serially cultivated human cells and their applications as a graft material", NAGOYA J. MED. SCI.,, vol. 58, 1995, pages 13 - 28, XP002927612 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916655B2 (en) 2001-11-22 2005-07-12 Nipro Corporation Cultured skin and method of manufacturing the same
US7497686B2 (en) 2004-09-02 2009-03-03 Odontis Ltd. Bone regeneration

Also Published As

Publication number Publication date
JP3043727B1 (en) 2000-05-22
AU1186000A (en) 2000-06-13
JP2000157624A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
JP6016751B2 (en) Cultured periodontal ligament cell sheet, production method and use thereof
JP3728750B2 (en) Cultured skin and method for producing the same
RU2428140C2 (en) Method of tooth formation, dentition and method of tissue formation
US20080039940A1 (en) Biological Tissue Sheet, Method Of Forming The Same And Transplantation Method By Using The Sheet
US20050214259A1 (en) Corneal endothelium-like sheet and method of constructing the same
WO2007037486A1 (en) Method for cultivation of hair follicular dermal sheath cell
JP3599701B2 (en) Cell engraftment method on three-dimensional structure surface
JP2010505580A (en) Cultured melanocytes on biopolymers
JP4991203B2 (en) Teeth manufacturing method
CN106890363B (en) Preparation method of engineered dental pulp
WO2010027008A1 (en) Method for forming tooth root-periodontal tissue unit and regenerated tooth
KR101503939B1 (en) Cartilage cell preparation method
JP2004331557A (en) Method for regenerating tooth germ
WO2000030695A1 (en) Mucosal epithelial cell sheet and method for producing the same
WO2005014070A1 (en) Method of bone regeneration
KR20030050168A (en) Bioartificial skin prepared from mesenchymal cells of hair follicle
WO2007029676A1 (en) Biological tissue sheet and method for preparation thereof
WO2001066695A1 (en) Tissue compositions using cultured fibroblasts and keratinocytes and methods of use thereof
US7887829B1 (en) Mucosal cell composites and methods
KR100377784B1 (en) Bioartificial skin prepared from mesenchymal cells of hair follicle
WO2000023582A1 (en) Gene transfer cell sheet and process for preparing the same
JP2006280234A (en) Cell proliferation or differentiation method
JP4313069B2 (en) Animal cell culture medium and animal cell culture method using the same
Ueda Applied Tissue Engineering
KR0156685B1 (en) How to test the effectiveness of drugs using three-dimensional culture

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 11860

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载